BfArM - Bundesinstitut für Arzneimittel und Medizinprodukte

Navigation und Service

BfArM - Impulsbericht 2023

  1. BfArM Impulsbericht

Q&As on the implementation of the outcome of the Art. 31 referral on angiotensin-II-receptor antagonists (sartans) containing a tetrazole group

07.07.2021

Q&As on the implementation of the outcome of the Art. 31 referral on angiotensin-II-receptor antagonists (sartans) containing a tetrazole group

Q&As on the implementation of the outcome of the Art. 31 referral on angiotensin-II-receptor antagonists (sartans) containing a tetrazole group PDF, 297KB, barrierefrei ⁄ barrierearm